Saba Shaikh, MD, talks with Thorsten Kühn, PhD, about the AXSANA/EUBREAST 3 study, which showed that, in patients who convert from clinically node-positive to node-negative breast cancer, less invasive surgical staging procedures are associated with a low axillary recurrence rate. These findings reinforce efforts to minimize surgical morbidity without compromising oncologic outcomes.
▷ Estimated Read Time:
1–2 minutes
SABCS Snippets: Results of the AXSANA/EUBREAST 3 Study
Connect with thousands of basic and translational scientists, multidisciplinary clinicians, regulatory and pharmaceutical partners, survivors, and patient advocates at the 49th annual San Antonio Breast Cancer Symposium. Complete your registration by Friday, September 25, to take advantage of discounted early registration rates.
Share: